FLT3 and acute myeloid leukemia: Additionally, with our unbiased approach to comprehensively assess OSM levels in AML patients, we observed a clear increase in the number of FLT3-ITD+ AML patients with active disease and a trend toward worsened survival in OSMhigh AML patients.